As we continue to fight COVID-19 in the United States, SCDAA is compiling resources to assist the sickle cell community during the pandemic. The Centers for Disease Control and Prevention (CDC) lists sickle cell disease (SCD) as one of the populations vulnerable to severe COVID-19. SCDAA provides support to patients and CBOs assisting SCD patients during this time. 

Based on current information, SCDAA recommends that people with sickle cell disease receive COVID-19 vaccination. Read SCDAA’s Statement on COVID-19 Vaccines (Updated 9/24/21).

COVID-19 Resources

In addition, SCDAA’s Medical and Research Advisory Committee is committed to providing up-to-date information and developments regarding the virus, the vaccine and more. View their advisories and recommendations for SCD patients and their caregivers below. 

MARAC Advisory Statement: Update About COVID-19

-December 23, 2021

MARAC Advisory Statement Update About COVID-19 Vaccines

-September 21, 2021

MARAC Issues Updated COVID-19 Guidance

-August 21, 2021

MARAC Advisory Statement: COVID-19 Vaccines

-December 15, 2020

MARAC Advisory Statement on Post-secondary and Boarding School Education in the Age of COVID-19

-July 31, 2020

MARAC Advisory Statement for SCD Patients Who are Teachers, Administrators, and Other Support Staff during School Reopening

-July 31, 2020

SCDAA MARAC Position on 2020 School Reopening

-July 27, 2020

MARAC Advisory Statement Regarding SCD Patients during the time of “Reopening” the U.S. Economy

-April 30, 2020

Sickle Cell Disease and COVID-19: Provider Advisory

-March 18, 2020

Health Alert for People with Sickle Cell Disease and their Caregivers

-March 17, 2020